Inventor
LIU QINGSONG
CN23 patents
⚠️ This page may combine multiple inventors who share the name “LIU QINGSONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PRECEDO PHARMACEUTICALS CO LTD
6 patentsUS12517114B2Jan 6, 2026
Primary gastrointestinal stromal tumor cell culture medium, culture method and application thereof
PRECEDO PHARMACEUTICALS CO LTD0 citations56
US12590951B2Mar 31, 2026
Culture medium and culture method for primary cells of intestinal cancer
PRECEDO PHARMACEUTICALS CO LTD0 citations49
US10975082B2Apr 13, 2021
Inhibitor of FLT3 kinase and use thereof
PRECEDO PHARMACEUTICALS CO LTD0 citations48
US10781214B2Sep 22, 2020
Kinase inhibitor against wild-type and mutant EGFR
PRECEDO PHARMACEUTICALS CO LTD0 citations48
US10793543B2Oct 6, 2020
Selective C-KIT kinase inhibitor
PRECEDO PHARMACEUTICALS CO LTD0 citations46
US10350210B2Jul 16, 2019
EGFR and ALK dual inhibitor
PRECEDO PHARMACEUTICALS CO LTD0 citations36
HEFEI INST PHYSICAL SCI CAS
5 patentsUS9814709B2Nov 14, 2017
Bruton's tyrosine kinase inhibitor
HEFEI INST PHYSICAL SCI CAS16 citations82
US11602534B2Mar 14, 2023
Pyrimidine derivative kinase inhibitors
HEFEI INST PHYSICAL SCI CAS0 citations59
US12318398B2Jun 3, 2025
MST1 kinase inhibitor and use thereof
HEFEI INST PHYSICAL SCI CAS0 citations50
US10266535B2Apr 23, 2019
Inhibitor of FLT3 kinase and use thereof
HEFEI INST PHYSICAL SCI CAS0 citations40
US10669238B2Jun 2, 2020
Irreversible bruton's tyrosine kinase inhibitor
HEFEI INST PHYSICAL SCI CAS0 citations38
TARAPEUTICS SCIENCE INC
4 patentsUS12404244B2Sep 2, 2025
Pan-KIT kinase inhibitor having quinoline structure and application thereof
TARAPEUTICS SCIENCE INC0 citations56
US12221448B2Feb 11, 2025
Selective PI3Kδ inhibitor and use thereof
TARAPEUTICS SCIENCE INC0 citations55
US12162876B2Dec 10, 2024
Indazole kinase inhibitor and use thereof
TARAPEUTICS SCIENCE INC0 citations47
US10647700B2May 12, 2020
EZH2 inhibitor and use thereof
TARAPEUTICS SCIENCE INC0 citations30